U.S. Department of Health & Human Services
U.S. Government: Agencies/Departments/Divisions | Cabinet-Level Federal Department
Recent News About U.S. Department of Health & Human Services
-
The Centers for Medicare & Medicaid Services (CMS) has announced new measures aimed at improving care quality and increasing transparency for Medicare beneficiaries.
-
The U.S. Department of Health and Human Services (HHS) has released a peer-reviewed report titled "Treatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices," examining the risks associated with medical interventions aimed at...
-
The U.S. Department of Health and Human Services (HHS) has announced a $2 million Caregiver Artificial Intelligence Prize Competition aimed at supporting the approximately one in four Americans who serve as caregivers for older adults and people...
-
Richard Pazdur, M.D., has been appointed as the new director of the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration (FDA), according to an announcement from the U.S. Department of Health and Human Services...
-
The U.S. Department of Health and Human Services (HHS) announced on November 10, 2025, that the Food and Drug Administration (FDA) will begin removing broad “black box” warnings from hormone replacement therapy (HRT) products used to treat...
-
The Centers for Medicare & Medicaid Services (CMS) has announced a new initiative to address high prescription drug costs within Medicaid.
-
All 50 states have applied to participate in the $50 billion Rural Health Transformation Program, according to an announcement from the Centers for Medicare & Medicaid Services (CMS).
-
The U.S. Food and Drug Administration (FDA) has announced measures to limit the sale of unapproved ingestible fluoride prescription drug products intended for children.
-
The U.S. Food and Drug Administration (FDA) has announced new measures aimed at making the development of biosimilar medicines faster and less expensive.
-
The U.S. Food and Drug Administration (FDA) has named nine recipients of the new Commissioner’s National Priority Voucher (CNPV) pilot program.
-
The Centers for Disease Control and Prevention (CDC) has updated its immunization schedules for adults and children, shifting to an individual-based approach for COVID-19 vaccination and recommending that toddlers receive the varicella...
-
The Administration for Community Living (ACL), part of the U.S. Department of Health and Human Services, has announced $60 million in grants to support older adults and people with disabilities across the United States.
-
The U.S. Department of Health and Human Services (HHS) Office for Civil Rights (OCR) has reached a settlement with Cadia Healthcare Facilities over potential violations of the Health Insurance Portability and Accountability Act of 1996 (HIPAA)...
-
The U.S. Department of Health and Human Services (HHS) announced on September 30, 2025, that it will double the funding for the Childhood Cancer Data Initiative at the National Cancer Institute.
-
The U.S. Department of Health and Human Services (HHS) Office for Civil Rights (OCR) has referred Harvard University to the department’s office responsible for suspension and debarment proceedings, a step that could lead to the university being...
-
Anthony Letai, MD, Ph.D., was officially sworn in as director of the National Cancer Institute (NCI) on September 29, 2025.
-
The U.S. Department of Health and Human Services (HHS), through the Administration for Children and Families (ACF), has announced that more than $61 million in supplemental nutrition funding will be distributed to over 290 Head Start programs...
-
The U.S. Department of Health and Human Services’ Office for Civil Rights (OCR) has reached a resolution agreement with the Idaho Department of Health and Welfare to address a civil rights complaint involving the institutionalization of a teenager...
-
The Substance Abuse and Mental Health Services Administration (SAMHSA), part of the U.S. Department of Health and Human Services, has announced over $45 million in supplemental funding for State Opioid Response program recipients.
-
The U.S. Food and Drug Administration (FDA) this week approved Vykat XR, developed by Soleno Therapeutics, as the first treatment for Prader-Willi Syndrome (PWS).